NCT00638781View on ClinicalTrials.gov

Desmoteplase in Acute Ischemic Stroke (DIAS)

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
Stroke
Interventions
DRUG

Desmoteplase

Desmoteplase 62.5 µg/kg BW

DRUG

Desmoteplase

Desmoteplase 90 µg/kg BW

DRUG

Desmoteplase

Desmoteplase 125 µg/kg BW

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Prof. Dr. Werner Hacke, Heidelberg

All Listed Sponsors
lead

PAION Deutschland GmbH

INDUSTRY

NCT00638781 - Desmoteplase in Acute Ischemic Stroke (DIAS) | Biotech Hunter | Biotech Hunter